Prophylactic human papillomavirus vaccines: the beginning of the end of cervical cancer
- 10 September 2004
- journal article
- review article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 14 (5) , 751-761
- https://doi.org/10.1111/j.1048-891x.2004.014505.x
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Vaccine and antibody-directed T cell tumour immunotherapyBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2004
- Virologic Versus Cytologic Triage of Women With Equivocal Pap Smears: A Meta-analysis of the Accuracy To Detect High-Grade Intraepithelial NeoplasiaJNCI Journal of the National Cancer Institute, 2004
- Safety and immunogenicity of a peptide containing the cross-neutralization epitope of HPV16 L2 administered nasally in healthy volunteersVaccine, 2003
- Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysisBritish Journal of Cancer, 2003
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003
- Cervical cancer vaccines: progress and prospectsJournal of the Society for Gynecologic Investigation, 2002
- High incidence of cervical human papillomavirus infection in women during their first sexual relationshipBJOG: An International Journal of Obstetrics and Gynaecology, 2002
- HPV induced cervical carcinogenesis: molecular basis and vaccine developmentZentralblatt Fur Gynakologie, 2002
- Prevention of cervix cancerCritical Reviews in Oncology/Hematology, 2000
- The E5 Transforming Gene of Bovine Papillomavirus Encodes a Small, Hydrophobic PolypeptideScience, 1986